Clinical Evaluation of Silk'n Glide for Face
Clinical Evaluation of Silk'n Glide for Face
This is a clinical study to determine the efficacy and safety of the Glide, hair removal
 photo-depilation device, for removing facial hairs. During the first stage, the subjects will
 perform up to 6 face treatments, two weeks apart. The treatment's safety and efficiency will
 be evaluated at 4 weeks of after last treatment and at 12 weeks after last treatment.
Study efficacy assessment:

 Comparison of hair counts before treatments to 4 and 12 weeks follow up visits.

 Study safety assessment:

 1. Reported errors and near errors using the device

 2. Device malfunctions which relate to device safety

 3. Device related adverse events

 4. Non device related adverse events (secondary endpoint)
Inclusion Criteria:

 1. Presence of unwanted hairs on the face

 2. Skin Type I to IV (Fitzpatrick)

 3. Adults older than 21 years of age but not more than 60 years of age.

 4. Must be either post-menopausal or surgically steri-lized, or using a medically
 acceptable form of birth control (i.e., oral contraceptives, IUD, contraceptive
 implant, barrier methods with spermicide or absti-nence).

 5. Informed consent agreement by the subject.

 6. Willingness to follow the treatment schedule and post treatment care.

 Exclusion Criteria:

 1. Malignant or pre-malignant pigmented lesions in the area to be treated.

 2. Scarring or infection of the area to be treated.

 3. Known photosensitivity.

 4. Pregnancy or lactating

 5. Subjects with Diabetes (Type I or II).

 6. Presence of a suntan in the area to be treated.

 7. Use of medication known to induce photosensitivity.

 8. Subject is on anticoagulative medication or throm-boembolic condition.

 9. Subjects with a pacemaker or internal defibrillator.

 10. Use of NSAIDS two weeks prior to, and two weeks following the treatment.

 11. Subjects that use waxing or other methods of photo-epilation 3 months prior to
 treatment.

 12. Subjects that have been exposed to strong sunlight or an artificial tanning machine
 during the past 4 weeks

 13. Subjects wearing a tattoo or permanent makeup on the area to be treated

 14. Subjects with dark brown or black spots, such as large freckles, birth marks, moles or
 warts on the area to be treated

 15. Subjects with Eczema, psoriasis, lesions, open wounds or active infections, such as
 cold sores in the area to be treated

 16. Subjects with history of keloidal scar formation

 17. Subjects with history of herpes outbreaks in the area of treatment, unless you have
 consulted your physician and received preventative treatment before using GlideTM

 18. Subjects with epilepsy

 19. Subjects using incontinence device, insulin pump, other active devices [NB: Protocol
 excludes pace-makers and internal defibrillators.]

 20. Subjects with a history of skin cancer or areas of po-tential skin malignancies

 21. Subjects who have received radiation therapy or chemotherapy treatments within the
 past 3 months